Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by
expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown
function. To distinguish between "loss of function" and "gain of function" models
of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice
heterozygous for Hdh inactivation were phenotypically normal, whereas
homozygosity resulted in embryonic death. Homozygotes displayed abnormal
gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin
is critical early in embryonic development, before the emergence of the nervous
system. That Hdh inactivation does not mimic adult HD neuropathology suggests
that the human disease involves a gain of function.
| Original language | English |
|---|---|
| Pages (from-to) | 407-410 |
| Number of pages | 4 |
| Journal | Science |
| Volume | 269 |
| DOIs | |
| Publication status | Published - 1995 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Inactivation of the mouse Huntington’s disease gene homolog (Hdh)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver